Stay updated on Immunotherapy in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in Melanoma Clinical Trial page.

Latest updates to the Immunotherapy in Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe study record for the stage IV melanoma trial is displayed with its study design, treatment arms, eligibility criteria, outcome measures, locations, and publications, replacing the access-denied page.SummaryDifference55%

- Check13 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA sitewide NIH notice about changes in terminology appears above the page, and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, with an accompanying header and navigation indicating an access issue on the record for the NCT02523313 study.SummaryDifference18%

- Check62 days agoChange DetectedRevision label updated from v3.6.6 to v3.7.0, indicating a system update; the visible study details remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Melanoma Clinical Trial page.